141 related articles for article (PubMed ID: 10448117)
21. RET/PCM-1: a novel fusion gene in papillary thyroid carcinoma.
Corvi R; Berger N; Balczon R; Romeo G
Oncogene; 2000 Aug; 19(37):4236-42. PubMed ID: 10980597
[TBL] [Abstract][Full Text] [Related]
22. Genetic mutations in thyroid carcinoma.
Taccaliti A; Boscaro M
Minerva Endocrinol; 2009 Mar; 34(1):11-28. PubMed ID: 19209125
[TBL] [Abstract][Full Text] [Related]
23. Expression of PLAG1 and HMGIC proteins and fusion transcripts in radiation-associated pleomorphic adenomas.
Enlund F; Nordkvist A; Sahlin P; Mark J; Stenman G
Int J Oncol; 2002 Apr; 20(4):713-6. PubMed ID: 11894114
[TBL] [Abstract][Full Text] [Related]
24. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer.
Tomlins SA; Laxman B; Dhanasekaran SM; Helgeson BE; Cao X; Morris DS; Menon A; Jing X; Cao Q; Han B; Yu J; Wang L; Montie JE; Rubin MA; Pienta KJ; Roulston D; Shah RB; Varambally S; Mehra R; Chinnaiyan AM
Nature; 2007 Aug; 448(7153):595-9. PubMed ID: 17671502
[TBL] [Abstract][Full Text] [Related]
25. Detection of a t(1;22)(q23;q12) translocation leading to an EWSR1-PBX1 fusion gene in a myoepithelioma.
Brandal P; Panagopoulos I; Bjerkehagen B; Gorunova L; Skjeldal S; Micci F; Heim S
Genes Chromosomes Cancer; 2008 Jul; 47(7):558-64. PubMed ID: 18383210
[TBL] [Abstract][Full Text] [Related]
26. Comparable transforming capacities and differential gene expression patterns of variant FUS/CHOP fusion transcripts derived from soft tissue liposarcomas.
Schwarzbach MH; Koesters R; Germann A; Mechtersheimer G; Geisbill J; Winkler S; Niedergethmann M; Ridder R; Buechler MW; von Knebel Doeberitz M; Willeke F
Oncogene; 2004 Sep; 23(40):6798-805. PubMed ID: 15286712
[TBL] [Abstract][Full Text] [Related]
27. Expression profiling of t(12;22) positive clear cell sarcoma of soft tissue cell lines reveals characteristic up-regulation of potential new marker genes including ERBB3.
Schaefer KL; Brachwitz K; Wai DH; Braun Y; Diallo R; Korsching E; Eisenacher M; Voss R; Van Valen F; Baer C; Selle B; Spahn L; Liao SK; Lee KA; Hogendoorn PC; Reifenberger G; Gabbert HE; Poremba C
Cancer Res; 2004 May; 64(10):3395-405. PubMed ID: 15150091
[TBL] [Abstract][Full Text] [Related]
28. PLAG1 fusion oncogenes in lipoblastoma.
Hibbard MK; Kozakewich HP; Dal Cin P; Sciot R; Tan X; Xiao S; Fletcher JA
Cancer Res; 2000 Sep; 60(17):4869-72. PubMed ID: 10987300
[TBL] [Abstract][Full Text] [Related]
29. [Molecular techniques lead to the first insights into the pathophysiology of salivary gland adenomas].
Kas K
Verh K Acad Geneeskd Belg; 2001; 63(1):35-40. PubMed ID: 11284386
[TBL] [Abstract][Full Text] [Related]
30. Chromosomal aberrations in solid tumors.
Chinnaiyan AM; Palanisamy N
Prog Mol Biol Transl Sci; 2010; 95():55-94. PubMed ID: 21075329
[TBL] [Abstract][Full Text] [Related]
31. WIF1, an inhibitor of the Wnt pathway, is rearranged in salivary gland tumors.
Queimado L; Lopes CS; Reis AM
Genes Chromosomes Cancer; 2007 Mar; 46(3):215-25. PubMed ID: 17171686
[TBL] [Abstract][Full Text] [Related]
32. Abnormal expression of cell cycle regulators in FUS-CHOP carrying liposarcomas.
Olofsson A; Willén H; Göransson M; Engström K; Meis-Kindblom JM; Stenman G; Kindblom LG; Aman P
Int J Oncol; 2004 Nov; 25(5):1349-55. PubMed ID: 15492825
[TBL] [Abstract][Full Text] [Related]
33. Search for NTRK1 proto-oncogene rearrangements in human thyroid tumours originated after therapeutic radiation.
Bounacer A; Schlumberger M; Wicker R; Du-Villard JA; Caillou B; Sarasin A; Suárez HG
Br J Cancer; 2000 Jan; 82(2):308-14. PubMed ID: 10646882
[TBL] [Abstract][Full Text] [Related]
34. [Molecular diagnosis of liposarcomas: identification of the chimeric genes FUS/CHOP and EWS/CHOP].
Kekeeva TV; Riazantseva AA; Anreeva IuIu; Zavalishina LE; Babenko OV; Zaletaev DV; Petrov AN; Frank GA
Arkh Patol; 2009; 71(5):32-5. PubMed ID: 19938700
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic dysregulation in thyroid neoplasia.
Kondo T; Asa SL; Ezzat S
Endocrinol Metab Clin North Am; 2008 Jun; 37(2):389-400, ix. PubMed ID: 18502333
[TBL] [Abstract][Full Text] [Related]
36. Fusion genes in solid tumors: an emerging target for cancer diagnosis and treatment.
Parker BC; Zhang W
Chin J Cancer; 2013 Nov; 32(11):594-603. PubMed ID: 24206917
[TBL] [Abstract][Full Text] [Related]
37. Chromosomal abnormalities and tumor development: from genes to therapeutic mechanisms.
Cobaleda C; Pérez-Losada J; Sánchez-García I
Bioessays; 1998 Nov; 20(11):922-30. PubMed ID: 9872058
[TBL] [Abstract][Full Text] [Related]
38. [Oncogenes and the malignancy process].
Mares J; Sedlácek Z; Goetz P
Cas Lek Cesk; 1996 May; 135(11):335-9. PubMed ID: 8706068
[TBL] [Abstract][Full Text] [Related]
39. Perspective: chromosomal translocations can affect genes controlling gene expression and differentiation--why are these functions targeted?
Rabbitts TH
J Pathol; 1999 Jan; 187(1):39-42. PubMed ID: 10341705
[TBL] [Abstract][Full Text] [Related]
40. Translocations, cancer and the puzzle of specificity.
Barr FG
Nat Genet; 1998 Jun; 19(2):121-4. PubMed ID: 9620766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
